Search research articles
Contact Us
Filters
Showing results (131-140 of 138) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 138 results.
Eclinicalmedicine
|
October 9, 2024
Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial
Min Yan, Quchang Ouyang, Tao Sun, et al.
The Lancet. Oncology
|
May 11, 2025
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
Jian Zhou, Li Bai, Jia Luo, et al.
Annals of Translational Medicine
|
January 20, 2023
Apatinib in the treatment of gastric cancer in Henan Province: a multicenter prospective real-world observational study (Ahead-HAP01)
Yijie Ma, Weijie Zhao, Peichun Sun, et al.
Frontiers in Medicine
|
April 3, 2026
Heterogeneous impact of tea consumption on COPD risk in smokers: insights from the PIFCOPD study
Yijing Li, Jiping Liao, Ruiying Wang, et al.
BMC Medicine
|
May 5, 2023
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study
Jin Li, Shukui Qin, Lu Wen, et al.
Respiratory Research
|
May 25, 2023
Ambient fine particulate matter and allergic symptoms in the middle-aged and elderly population: results from the PIFCOPD study
Shanshan Wei, Jiping Liao, Tao Xue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2024
Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial
Ruinuo Jia, Tanyou Shan, Anping Zheng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 24, 2026
Deulorlatinib (TGRX-326) in ALK gene fusion positive non-small cell lung cancer after failure of second-generation inhibitors (DRAGON): a single-arm, multicenter, phase 2 trial
Jie Huang, Gang Chen, Zhehai Wang, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 138) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 138 results.
Eclinicalmedicine
|
October 9, 2024
Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial
Min Yan, Quchang Ouyang, Tao Sun, et al.
The Lancet. Oncology
|
May 11, 2025
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
Jian Zhou, Li Bai, Jia Luo, et al.
Annals of Translational Medicine
|
January 20, 2023
Apatinib in the treatment of gastric cancer in Henan Province: a multicenter prospective real-world observational study (Ahead-HAP01)
Yijie Ma, Weijie Zhao, Peichun Sun, et al.
Frontiers in Medicine
|
April 3, 2026
Heterogeneous impact of tea consumption on COPD risk in smokers: insights from the PIFCOPD study
Yijing Li, Jiping Liao, Ruiying Wang, et al.
BMC Medicine
|
May 5, 2023
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study
Jin Li, Shukui Qin, Lu Wen, et al.
Respiratory Research
|
May 25, 2023
Ambient fine particulate matter and allergic symptoms in the middle-aged and elderly population: results from the PIFCOPD study
Shanshan Wei, Jiping Liao, Tao Xue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2024
Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial
Ruinuo Jia, Tanyou Shan, Anping Zheng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 24, 2026
Deulorlatinib (TGRX-326) in ALK gene fusion positive non-small cell lung cancer after failure of second-generation inhibitors (DRAGON): a single-arm, multicenter, phase 2 trial
Jie Huang, Gang Chen, Zhehai Wang, et al.
Page
of 14